Birgit Wilding
6PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 23, 2025
Discovery of Carbodiimide Warheads to Selectively and Covalently Target Aspartic Acid in KRASG12D.Ludovica S Sirocchi, Maximilian Scharnweber, Sarah Oberndorfer
|Sep 09, 2024
Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers.Birgit Wilding, Lydia Woelflingseder, Anke Baum
|Jul 26, 2022
Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling.Birgit Wilding, Dirk Scharn, Dietrich Böse
|Feb 07, 2022
Chemoenzymatic one-pot reaction from carboxylic acid to nitrile via oxime.Melissa Horvat, Victoria Weilch, Robert Rädisch
|Dec 15, 2017
Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766).Nicola E A Chessum, Swee Y Sharp, John J Caldwell
|Dec 23, 2016
Discovery of a Chemical Probe Bisamide (CCT251236): An Orally Bioavailable Efficacious Pirin Ligand from a Heat Shock Transcription Factor 1 (HSF1) Phenotypic Screen.Matthew D Cheeseman, Nicola E A Chessum, Carl S Rye
Pageof 1
Frequent Collaborators
2 joint publications
Keith Jones
2 joint publications
Ralph A Neumüller
2 joint publications
Flavio Solca
2 joint publications
Daniel Gerlach
1 joint publications
Nicola E A Chessum
1 joint publications
A Elisa Pasqua
1 joint publications
Krzysztof M Zak
1 joint publications
Bugra Ozer
1 joint publications
Mark Stubbs
1 joint publications
Paul A Clarke
